Marco Del Buono (@marcodelbuono3) 's Twitter Profile
Marco Del Buono

@marcodelbuono3

MD, Cardiologist, PhD, Fondazione Policlinico Gemelli, Rome, 🇮🇹
Former Research Fellow at VCU 🇺🇸

ID: 1124684985678614528

calendar_today04-05-2019 14:39:31

534 Tweet

1,1K Followers

777 Following

Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

Excellent overview of clinical trials (completed and ongoing) of anti-inflammatories in cardiovascular disease ahajournals.org/doi/abs/10.116… ATVB: An AHA Journal

Excellent overview of clinical trials (completed and ongoing) of anti-inflammatories in cardiovascular disease ahajournals.org/doi/abs/10.116… <a href="/atvbahajournals/">ATVB: An AHA Journal</a>
Marco Del Buono (@marcodelbuono3) 's Twitter Profile Photo

Good news! My work has received over 500 views since publication! Read it here onlinelibrary.wiley.com/doi/10.1111/ec… #ViewsMilestone

Massimiliano Camilli (@massimi78530343) 's Twitter Profile Photo

🫀Interested to know something more on application of echocardiographic LA Stiffness in AHF pts?⚡️Read our latest article🔬📚 trying to reclassify conventional diastolic function metrics in this population💣 pubmed.ncbi.nlm.nih.gov/39466444/

AntonioAbbate (@abbateantonio) 's Twitter Profile Photo

Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis pubmed.ncbi.nlm.nih.gov/39939545/ Thanks Beth and Gad for leading this effort - a good start to support the way further UVA CVRC UVA Cardio Benjamin Van Tassell

Journal of Cardiovascular Pharmacology (@jcvponline) 's Twitter Profile Photo

Optimizing Digoxin Use in Critically Ill Patients: Lessons from a Retrospective Study pubmed.ncbi.nlm.nih.gov/39812525 Marco Del Buono simone filomia #Digoxin #AtrialFibrillation #CriticalCare #Pharmacology #Cardiology

Optimizing Digoxin Use in Critically Ill Patients: Lessons from a Retrospective Study
pubmed.ncbi.nlm.nih.gov/39812525
<a href="/MarcoDelBuono3/">Marco Del Buono</a> <a href="/simonefilomia/">simone filomia</a>
#Digoxin #AtrialFibrillation #CriticalCare #Pharmacology #Cardiology
Journal of Cardiovascular Pharmacology (@jcvponline) 's Twitter Profile Photo

Indobufen: A Game-Changer for Aspirin Hypersensitivity or Just a Niche Alternative? pubmed.ncbi.nlm.nih.gov/40053571 Marco Del Buono simone filomia #Cardiology #AspirinHypersensitivity #Indobufen #Antiplatelet #Pharmacology

Indobufen: A Game-Changer for Aspirin Hypersensitivity or Just a Niche Alternative?
pubmed.ncbi.nlm.nih.gov/40053571
<a href="/MarcoDelBuono3/">Marco Del Buono</a> <a href="/simonefilomia/">simone filomia</a>
#Cardiology #AspirinHypersensitivity #Indobufen #Antiplatelet #Pharmacology
FRANCESCO BURZOTTA (@burzotta_f) 's Twitter Profile Photo

We have some days that we feel as more important than others. Yesterday was one of those. Great kick-off day @Maranello for the cooperation between the #Cardiology Team of Policlinico Gemelli and Med-Ex (Ferrari Medical Partner) to promote workers’ healthness in Ferrari!

We have some days that we feel as more important than others. Yesterday was one of those. Great kick-off day @Maranello for the cooperation between the #Cardiology Team of Policlinico Gemelli and Med-Ex (Ferrari Medical Partner) to promote workers’ healthness in <a href="/Ferrari/">Ferrari</a>!
Michele Golino (@micheleg1390) 's Twitter Profile Photo

Semaglutide: more than weight loss? Our new meta-analysis in EJPC Editor-in-Chief (~49,000 pts) shows a 17% reduction in new-onset AFib. Great collaboration! Link: doi.org/10.1093/eurjpc… Arturo Cesaro AntonioAbbate

Semaglutide: more than weight loss?
Our new meta-analysis in <a href="/EJPCEiC/">EJPC Editor-in-Chief</a>  (~49,000 pts) shows a 17% reduction in new-onset AFib.
Great collaboration!
Link: doi.org/10.1093/eurjpc…
<a href="/arturocesaro/">Arturo Cesaro</a> <a href="/AbbateAntonio/">AntonioAbbate</a>
AntonioAbbate (@abbateantonio) 's Twitter Profile Photo

Very cool .... but it should say "Takotsubo syndrome detected by Smartwatch" Austin Hogwood, PhD Paula Rodriguez Miguelez Michele Golino Marco Del Buono Cardiac Injury Detected by Smartwatch | New England Journal of Medicine nejm.org/doi/full/10.10…

Journal of Cardiovascular Pharmacology (@jcvponline) 's Twitter Profile Photo

Ivabradine Reduces Symptoms in POTS: Is Tachycardia the Culprit? pubmed.ncbi.nlm.nih.gov/40294227 AntonioAbbate #POTS #Ivabradine #HeartRate #AutonomicDisorders #CardiologyResearch

Ivabradine Reduces Symptoms in POTS: Is Tachycardia the Culprit?
pubmed.ncbi.nlm.nih.gov/40294227
<a href="/AbbateAntonio/">AntonioAbbate</a>

#POTS #Ivabradine #HeartRate #AutonomicDisorders #CardiologyResearch
AntonioAbbate (@abbateantonio) 's Twitter Profile Photo

Case Report of Fulminant Eosinophilic Myo-pericarditis Related to Checkpoint Inhibitors Complicated by Acute Heart Failure and Cardiac Tamponade academic.oup.com/ehjcr/article/… Francesco Moroni, MD Yacub Betz UVA Cardio UVA CVRC UVA Medicine

AntonioAbbate (@abbateantonio) 's Twitter Profile Photo

Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants | Circulation ahajournals.org/doi/10.1161/CI… Important observation from Alessio Gasperetti, MD PhD Nisha Gilotra #cardioimmunology

AntonioAbbate (@abbateantonio) 's Twitter Profile Photo

Inflammation in coronary atherosclerosis: diagnosis and treatment heart.bmj.com/content/111/17… MASTERPIECE by Giovanni Occhipinti and international team including Salvatore Brugaletta Daniela Pedicino Marco Del Buono Ramona Vinci Giuseppe Biondi-Zoccai Manel Sabate, Dominick Angiolillo Giovanna Liuzzo

Austin Hogwood, PhD (@hogwood_ac) 's Twitter Profile Photo

Our new paper is online ahead of print! We shows that anti-inflammatory treatment with IL-1 receptor antagonist (anakinra) improves peak VO2 in patients with heart failure (n=73) regardless of age stratification! journals.lww.com/cardiovascular…